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Abstract
Aims/hypothesis Adipocytes in obesity are characterised by
increased cell size and insulin resistance compared with
adipocytes isolated from lean patients. However, it is not
clear at present whether hypertrophy actually does drive
adipocyte insulin resistance. Thus, the aim of the present
study was to metabolically characterise small and large
adipocytes isolated from epididymal fat pads of mice fed a
high-fat diet (HFD).
Methods C57BL/6J mice were fed normal chow or HFD
for 8 weeks. Adipocytes from epididymal fat pads were
isolated by collagenase digestion and, in HFD-fed mice,
separated into two fractions according to their size by
filtration through a nylon mesh. Viability was assessed by
lactate dehydrogenase and 3-(4,5-dimethylthiazol-2-yl)-2,
5-diphenyltetrazolium assays. Basal and insulin-stimulated
d-[U-14C]glucose incorporation and lipolysis were mea-
sured. Protein levels and mRNA expression were determined
by western blot and real-time RT-PCR, respectively.
Results Insulin-stimulated D-[U-14C]glucose incorporation
into adipocytes isolated from HFD-fed mice was reduced
by 50% compared with adipocytes from chow-fed mice.
However, it was similar between small (average diameter
60.9±3.1 μm) and large (average diameter 83.0±6.6 μm)
adipocytes. Similarly, insulin-stimulated phosphorylation of
protein kinase B and AS160 were reduced to the same
extent in small and large adipocytes isolated from HFD-
mice. In addition, insulin failed to inhibit lipolysis in both
adipocyte fractions, whereas it decreased lipolysis by 30%
in adipocytes of chow-fed mice. In contrast, large and small
adipocytes differed in basal lipolysis rate, which was
twofold higher in the larger cells. The latter finding was
associated with higher mRNA expression levels of Atgl
(also known as Pnpla2) and Hsl (also known as Lipe) in
larger adipocytes. Viability was not different between small
and large adipocytes.
Conclusions/interpretation Rate of basal lipolysis but not in-
sulin responsiveness is different between small and large adi-
pocytes isolated from epididymal fat pads of HFD-fed mice.
Keywords Adipocyte size . Insulin resistance .
Insulin sensitivity
Abbreviations
Akt protein kinase B
ATGL adipose triacylglycerol lipase
HFD high-fat diet
HSL hormone-sensitive lipase
ipGTT intraperitoneal glucose tolerance test
LDH lactate dehydrogenase
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
Introduction
Adipocyte hypertrophy has been proposed to induce
adipose tissue dysfunction in obesity, while cell death of
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hypertrophic adipocytes is thought to be a driving force for
macrophage infiltration into adipose tissue [1] and large
adipocytes may secrete higher levels of pro-inflammatory
cytokines [2]. At a more metabolic level, hypertrophic
adipocytes may exhibit a reduced capacity to store and
retain NEFA, leading to elevated levels of circulating NEFA
[3]. In contrast, hyperplastic adipocytes may favour the
deposition of NEFA and thus protect other tissues such as
liver and skeletal muscle from lipotoxicity by sequestering
NEFA away from them [3]. In this regard, treatment with
thiazolidinediones has been shown to increase cellularity in
adipose tissue by promoting pre-adipocyte differentiation
and inducing apoptosis of large adipocytes, resulting in
smaller and more insulin-sensitive adipocytes [4]. Yet, most
studies comparing large and small adipocytes isolated them
from different participants/animals (small adipocytes from
lean, large adipocytes from obese) [5, 6]. Thus, differences
between large and small adipocytes could have resulted
from other factors that differ between lean and obese
sources [5, 6] and not from genuine biological differences
between large and small fat cells within the same biological
context.
Thus, the aim of the present study was to metabolically
characterise large versus small adipocytes isolated from the
same depot of mice fed a high-fat diet (HFD) for 8 weeks.
Such feeding is associated with whole-body insulin
resistance, but with minimal adipocyte cell death and
macrophage infiltration [1]. We hypothesised that insulin
responsiveness in large adipocytes is reduced compared
with small adipocytes isolated from the same fat pad.
Methods
Animals We used 6- to 8-week-old male C57BL6JOlaHsd
mice, which had free access to standard rodent diet or HFD
(D12331; Research Diets, New Brunswick, NJ, USA) for
8 weeks. HFD consisted of 56% of energy derived from fat,
28% from carbohydrate and 16% from protein. In total, 30
mice were used for this study. All protocols conformed to
the Swiss animal protection laws and were approved by the
Cantonal Veterinary Office in Zurich, Switzerland.
Intraperitoneal glucose tolerance test For the intraperito-
neal glucose tolerance test (ipGTT), mice were injected
intraperitoneally with 2 mg/g body weight glucose after
overnight fasting. Blood glucose concentration was mea-
sured with a glucometer (Accu-Check Aviva; Roche
Diagnostics, Rotkreuz, Switzerland) with blood from tail-
tip bleedings [7].
Cell separation and viability assessment Adipocytes isolat-
ed from HFD-fed mice were separated into two fractions
according to their size by filtration through a 60 μm nylon
mesh (Millipore, Zug, Switzerland). Cells caught on the mesh
(large adipocytes) were gently washed away into a separate
vial. After separation, adipocyte viability was assessed with a
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide assay (MTT) (Sigma, Buchs, Switzerland) as follows.
Small and large cells were incubated with 0.5 mg/ml MTT
for 1 h and salt was extracted from them with DMSO. The
amount of yellow MTT reduced to purple formazan was
measured spectrophotometrically (550–655 nm) with an
ELISA reader. A lactate dehydrogenase (LDH) release assay
using a nonradioactive cytotoxicity assay (CytoTox 96;
Promega, Dübendorf, Switzerland) was also performed.
LDH released into supernatant fraction was measured and
normalised to cell number in incubation medium.
Glucose incorporation into isolated white adipocytes Adi-
pocyte isolation and glucose incorporation were performed
as described previously [8] with the following adaptations.
Adipocytes (4-8% suspension [9]) were incubated for
60 min with D-[U-14C]glucose. In this setting, most of the
labelled glucose is incorporated into lipids and is therefore
a readout for lipid synthesis [10]. Where indicated, cells
were thereafter separated into two fractions according to
their size by filtration through a 60 μm nylon net filter.
Glucose incorporation was stopped by separating cells from
the medium by centrifugation (about 2000 g) through
phthalic acid dinonyl ester. Cells were then subjected to
liquid scintillation counting. Cell number was determined
with a Neubauer haematocytometer (Brand, Wertheim,
Germany) under the light microscope.
Cell size determination Aliquots of all adipocyte fractions
of each experiment were used to determine mean cell
diameters. Photographs of isolated adipocytes in the
haematocytometer were taken and images were analysed
using ImageJ software for quantification (National Insti-
tutes of Health, Bethesda, MD, USA). At least 100
adipocytes per fraction of four independent experiments
were analysed.
Lipolysis assays To assess lipolysis, cells were separated as
mentioned above and incubated in the absence or presence
of 100 nmol/l insulin or 1 μmol/l isoproterenol (Sigma) for
1 h. NEFA levels were measured using a method (ACS-
ACOD-MEHA) from Wako Chemicals (Neuss, Germany).
Glycerol content of the incubation medium was determined
using a colorimetric assay, as described [11].
RNA extraction and quantitative RT-PCR Total RNA was
extracted using a kit (RNeasy Lipid Tissue Mini Kit;
Qiagen, Basel, Switzerland). RNA (0.5 μg) was reverse-
transcribed with Superscript III Reverse Transcriptase
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(Invitrogen, Basel, Switzerland) using random hexamer
primer. Taqman was used for real-time PCR amplification.
The following PCR primers (Applied Biosystems, Rork-
reuz, Switzerland) were used: Hsl (also known as Lipe)
Mm00495359_m1, Atgl (also known as Pnpla2)
Mm00503040_m1. Relative gene expression was obtained
after normalisation to 36B4 (also known as Rplp0) RNA
(Applied Biosystems), using the formula 2−ΔΔcp.
Western blot Isolated and separated adipocytes were homo-
genised in a buffer containing 150 mmol/l NaCl, 50 mmol/
l Tris–HCl (pH 7.5), 1 mmol/l EGTA, 1% (vol./vol.) NP-40,
0.25% (vol./vol.) sodium deoxycholate, 1 mmol/l sodium
vanadate, 1 mmol/l NaF, 10 mmol/l sodium β-glycerophos-
phate, 100 nmol/l okadaic acid, 0.2 mmol/l phenylmethyl-
sulphonyl fluoride (PMSF) and a 1:1000 dilution of protease
inhibitor cocktail (Sigma). Protein concentration was deter-
mined using the bicinchoninic acid (BCA) assay (Pierce,
Rockford, IL, USA) and equivalent amounts of protein
(40 μg) were resolved by LDS-PAGE (4–12% gel;
NuPAGE; Invitrogen). Proteins were electro-transferred on
to nitrocellulose membranes (0.2 μm; BioRad, Reinach,
Switzerland) and immunoblotted for phosphoS473-protein
kinase B (Akt), phosphoT308-Akt, phosphoAS160 (Cell
Signalling, Beverly, MA, USA), anti-GLUT4 (gift from A.
Klip, The Hospital for Sick Children, Toronto, ON, Canada)
or anti-actin (Millipore, Zug, Switzerland). Membranes
were exposed in an Image Reader and analysed with an
Image Analyzer (FujiFilm, Dielsdorf, Switzerland).
Data analysis Statistical analyses were performed using
either Student’s t test or ANOVA test (Tukey’s multiple
comparisons test).
Results
Separation of adipocytes isolated from HFD-fed mice HFD
for 8 weeks significantly impaired glucose tolerance in
male C57BL6JOlaHsd mice compared with chow-fed
animals as assessed by an ipGTT (Fig. 1a). Adipocytes
isolated from HFD-fed mice were separated into two
Fig. 1 Reduced insulin responsiveness in small and hypertrophic
adipocytes isolated from HFD-fed mice. a Intraperitoneal glucose
tolerance test was performed in chow-fed (grey symbols) and HFD-
fed (black symbols) mice. Glucose (2 g/kg body weight) was injected
intraperitoneally and blood glucose levels measured at indicated time
points. Results are means±SEM of seven (chow-fed) to 24 (HFD-fed)
animals per group. *p<0.05, **p<0.01 (Student’s t test). b Represen-
tative photographs of adipocytes isolated from epididymal fat pads of
chow-fed or HFD-fed mice (scale bar, 250 µm), with graph (c)
showing mean adipocyte diameter of each fraction. Results represent
the mean±SEM of three to four independent experiments. *p<0.05,
**p<0.01 (ANOVA). d Adipocyte viability was assessed by an LDH
and (e) an MTT assay. Results represent the mean±SEM of four
independent experiments. f D-[14C]Glucose incorporation into isolated
adipocytes of chow-fed (grey bars), HFD-fed small (white bars) and
HFD-fed large (black bars) adipocyte fractions. Results represent the
mean±SEM of three to five independent experiments. *p<0.05, **p<
0.01 (ANOVA) compared with insulin-stimulated glucose incorpora-
tion into adipocytes of chow-fed mice. g Total cell lysates were
prepared from isolated adipocytes treated for 10 min with 100 nmol/
l human insulin (Ins). Lysates (40 μg) were resolved by LDS-PAGE
and immunoblotted with anti-phospho (p)S473-Akt, anti-pAS160 or
anti-actin antibody. Representative immunoblots are shown. Mem-
branes were exposed in an Image Reader and quantified (h) with
Image Analyzer. Results represent the mean±SEM of three indepen-
dent experiments. **p<0.01 (ANOVA) compared with chow-fed mice
b
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fractions by filtration through a 60 μm nylon mesh. For
each experiment, epididymal fat pads of two mice were
pooled. Small adipocytes (mean diameter 60.9±3.1 μm)
were significantly smaller than large fat cells (mean
diameter 83.0±6.6 μm; p<0.05) (Fig. 1b, c). For compar-
ison, mean diameter of adipocytes isolated from chow-fed
animals was 50.7±3.3 μm, significantly (p<0.01) smaller
only than the large adipocytes from high-fat fed mice
(Fig. 1b, c). To rule out the possibility of higher occurrence
of cell rupture/cell damage in one cell fraction compared
with the other after filtration through the nylon mesh, cell
viability was assessed by an MTT and LDH assay. As
depicted in Fig. 1d and e, viability of the two adipocyte cell
fractions was comparable.
No difference in insulin-stimulated glucose incorporation
between small and large adipocytes isolated from HFD-fed
mice In order to assess insulin responsiveness, D-[U-14C]
glucose incorporation into adipocytes was determined next.
The fold increase in insulin-stimulated glucose incorpora-
tion into both adipocyte fractions prepared from HFD-fed
mice was greatly reduced compared with adipocytes isolated
from chow-fed animals (Fig. 1f), but surprisingly there was no
difference in glucose incorporation between large and small
adipocytes in HFD-fed mice in response to insulin (Fig. 1f).
This observation held true when the fold-increase in insulin-
stimulated glucose incorporation was calculated per cell
surface or cell volume (data not shown). Accordingly, the
insulin-stimulated increase in phosphorylation of Akt on S473
and on T308 residues as well as of AS160 was similar in both
fractions, but clearly reduced compared with adipocytes
isolated from chow-fed mice (Fig. 1g, h). Similarly, protein
levels of GLUT4 were not different between small and large
adipocytes, but was decreased by approximately 35% com-
pared with adipocytes from chow-fed mice (data not shown).
Increased NEFA release from large epididymal adipocytes
isolated from HFD-fed mice In order to evaluate lipolysis,
concentrations of NEFA and glycerol were determined in
the incubation medium. Basal NEFA release per cell was
significantly higher in large than in small adipocytes
(Fig. 2a), a difference that was not significant when
controlled for surface area. This finding suggests that the
elevated lipolytic activity of the large adipocytes is a direct
effect of cell hypertrophy. Similar results for basal lipolysis
were obtained when release of glycerol was measured
(Fig. 2b). Isoproterenol-stimulated lipolysis was significantly
increased compared with basal NEFA release, but not
different between small and large adipocytes from HFD-fed
mice (Fig. 2a). Remarkably, the ability of insulin to inhibit
lipolysis was fully blunted in large and small adipocytes
compared with adipocytes from chow-fed mice (in which
lipolysis was inhibited by ∼30%) (Fig. 2c), a finding that is
consistent with the similar degree of insulin resistance
observed in signalling and glucose incorporation (Fig. 1d).
Adipose triacylglycerol lipase (ATGL) and hormone-
sensitive lipase (HSL) are key players in adipocyte lipolysis.
It has been suggested that ATGL and HSL may act in
coordination such that ATGL is the primary lipase responsible
for hydrolysing the first fatty acid from triacylglycerol and that
HSL is the primary diacylglycerol lipase [12]. Alternatively, it
has been proposed that HSL is the primary triacylglycerol
lipase responsible for catecholamine-stimulated lipolysis from
adipocytes and ATGL is the primary triacylglycerol lipase for
basal lipolysis [13]. Given the differences in basal lipolysis
rate between large and small adipocytes, mRNA expression
levels of these two lipases were determined. There was a slight
but significant increase in Atgl mRNA levels in large
adipocytes (Fig. 2d). Similarly, Hsl expression tended to be
higher in large adipocytes; however, this increase did not
reach statistical significance.
Discussion
Adipocytes from obese persons or animals compared with
those from lean persons or animals are characterised by
Fig. 2 Increased basal lipolysis in large adipocytes. a Basal and
isoproterenol-stimulated NEFA release from HFD small (white bars)
and HFD large (black bars) adipocytes. Results are means±SEM of
five (isoproterenol) to seven (basal) independent experiments. *p<
0.05 (Student’s t test). b Basal glycerol release from HFD small and
HFD large adipocytes. Results are means±SEM of three independent
experiments. *p<0.05 (Student’s t test). c Per cent inhibition of NEFA
release by insulin in chow-fed, HFD-fed small and HFD-fed large
adipocytes. Results represent the mean±SEM of three to five
independent experiments. d Quantitative RT-PCR detection of Atgl
and Hsl mRNA expression. The level of mRNA expression was
normalised to 36B4 RNA. Results represent the mean±SEM of three
independent experiments and are expressed relative to expression in
the HFD-small fraction. *p<0.05 (Student’s t test)
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increased cell size and decreased insulin-stimulated glucose
uptake [14, 15]. It has therefore been speculated that larger
adipocytes are more insulin resistant. Although this conclu-
sion is plausible, it is difficult to analyse the sole contribution
of cell size to insulin resistance independently of other
factors since cells are isolated from different individuals. It is
possible that these factors, along with or independently of
cell size, causatively contribute to the insulin resistance
observed in adipocytes derived from the obese.
To address this point, we have characterised larger
versus smaller adipocytes from the same fat depot of mice
fed HFD for 8 weeks. The time span of 8 weeks of HFD
was chosen to examine an early phase of obesity-induced
changes in adipose tissue. Macrophage infiltration of
adipose tissue and occurrence of adipocyte death may have
just started at this time point [1]. Yet, 8 weeks of fat-
enriched diet was already sufficient to induce whole-body
insulin resistance as demonstrated by a significantly
impaired ipGTT (Fig. 1a), by a reduction in insulin-
stimulated glucose incorporation (Fig. 1f) and by a blunted
capacity of insulin to inhibit lipolysis (Fig. 2c). Neverthe-
less, when comparing large to small adipocytes isolated
from HFD-fed mice, we did not detect any differences in
insulin responsiveness (Figs 1f and 2c). This observation
was true both for insulin-mediated stimulation of glucose
incorporation, as well as for the inhibition of lipolysis. It is still
possible that the severity of insulin resistance differs between
the extremes of adipocyte size. Yet for the cell size range of
most adipocytes composing the adipose tissue of HFD mice,
the data would suggest that the degree of cellular hypertrophy
is not a direct determinant of severity of adipocyte insulin
resistance. More probably, insulin resistance in adipocytes of
HFD-fed mice could be a secondary phenomenon to alter-
ations in the intra-fat depot environment, such as increased
release of pro-inflammatory cytokines and/or NEFA. These
would seem to similarly affect insulin sensitivity in larger
versus smaller adipocytes within the same fat depot.
One of the main findings in the present study is the
significant increase in basal lipolysis in large compared
with small adipocytes (Fig. 2a, b). This finding is in
accordance with a previous study showing a correlation of
adipocyte size with basal rates of lipolysis [16]. The latter
finding would imply increased circulating NEFA levels in
patients with adipocyte hypertrophy. Indeed, enlarged
adipocytes were found more frequently in patients with
obesity-related metabolic disorders [17], suggesting that
increased basal lipolysis of large adipocytes may directly
contribute to obesity-induced metabolic alterations, poten-
tially via deposition of lipids in liver and skeletal muscle
(lipotoxicity). It would be intriguing to assess whether, by
increasing local NEFA concentrations in adipose tissue,
large adipocytes contribute to the insulin resistance that
similarly develops in large versus small adipocytes.
Intriguingly, whereas NEFA-induced insulin resistance is a
well established phenomenon in skeletal muscle and liver,
results in adipocytes are somewhat controversial [18, 19],
leaving this putative mechanism unsettled.
In conclusion, adipocyte hypertrophy associated with
diet-induced obesity does not seem to be a direct
determinant of the severity of adipocyte insulin resistance.
Instead, larger adipocytes have a higher basal lipolysis rate
than smaller adipocytes. Hence, of the various alterations to
adipose tissue in obesity, adipocyte hypertrophy may
predominantly, albeit indirectly, contribute to whole-body
insulin resistance, e.g. by affecting the release of secreted
products like adipokines and NEFAs.
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